New York University: Programming the Immune System to Supercharge Cancer Cell Therapies
The first FDA-approved gene therapies are living drugs: immune cells taken from cancer patients engineered to target tumor cells. However, for many patients, these advanced therapies do not result in a long-lasting remission. Now,!-->…